Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.59 USD
5.28%
Updated:
Apr 29, 2024
Vivos Therapeutics Inc
Cash from Operating Activities
|
Vivos Therapeutics Inc
Cash from Operating Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Cash from Operating Activities
-$11.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$13.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Vivos Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-11.9m
USD
-11.9m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Cash from Operating Activities amounts to -11.9m USD.
What is Vivos Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-18%
-18%
Over the last year, the Cash from Operating Activities growth was 39%. The average annual Cash from Operating Activities growth rates for Vivos Therapeutics Inc have been -28% over the past three years , -18% over the past five years .
You don't have any saved screeners yet
